Related references
Note: Only part of the references are listed.Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group
Hitoshi Ikushima et al.
JOURNAL OF RADIATION RESEARCH (2022)
Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial
Casey W. Williamson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
Henrike Westerveld et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial
Naoya Murakami et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)
Human papillomavirus-independent cervical cancer
Andreina Fernandes et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
Ikumi Kuno et al.
SCIENTIFIC REPORTS (2021)
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Richard Pötter et al.
LANCET ONCOLOGY (2021)
Why not de-intensification for uterine cervical cancer?
Naoya Murakami et al.
GYNECOLOGIC ONCOLOGY (2021)
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
N. Colombo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
L. Cabel et al.
ESMO OPEN (2021)
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
Jyoti Mayadev et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.
Domenica Lorusso et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie et al.
JAMA ONCOLOGY (2019)
Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer
Yasuhiko Ebina et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results
Franziska Walter et al.
BRACHYTHERAPY (2018)
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience
Jie Lee et al.
GYNECOLOGIC ONCOLOGY (2017)
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
Loren K. Mell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology
Gyorgy Kovacs et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
Primoz Strojan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer
Naoya Murakami et al.
BMC CANCER (2016)
Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy
Matthew Susko et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study
Kathrin Kirchheiner et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer
Kari Tanderup et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retro EMBRACE study
Lars Fokdal et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer
Ken Yoshida et al.
BRACHYTHERAPY (2015)
Filling the gap in central shielding: three-dimensional analysis of the EQD2 dose in radiotherapy for cervical cancer with the central shielding technique
Tomoaki Tamaki et al.
JOURNAL OF RADIATION RESEARCH (2015)
Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies
Naoya Murakami et al.
RADIATION ONCOLOGY (2014)
Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: A multi-institutional study
Primoz Petric et al.
RADIOTHERAPY AND ONCOLOGY (2013)
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy
Akila N. Viswanathan et al.
BRACHYTHERAPY (2012)
Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedule
Takafumi Toita et al.
GYNECOLOGIC ONCOLOGY (2012)
DOSE-VOLUME HISTOGRAM PARAMETERS AND LOCAL TUMOR CONTROL IN MAGNETIC RESONANCE IMAGE-GUIDED CERVICAL CANCER BRACHYTHERAPY
Johannes C. A. Dimopoulos et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer
Richard Potter et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours
Akila N. Viswanathan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiotogy
R Potter et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group* (I):: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
C Haie-Meder et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Share Paper
